My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WORK PLANS
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
T
>
TILLIE LEWIS
>
1444
>
2900 - Site Mitigation Program
>
PR0546381
>
WORK PLANS
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/13/2021 3:31:27 PM
Creation date
4/13/2021 3:28:54 PM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
WORK PLANS
RECORD_ID
PR0546381
PE
2950
FACILITY_ID
FA0026287
FACILITY_NAME
VIA DEL ORO PARTNERS LLC
STREET_NUMBER
1444
STREET_NAME
TILLIE LEWIS
STREET_TYPE
DR
City
STOCKTON
Zip
95206
APN
163350030
CURRENT_STATUS
01
SITE_LOCATION
1444 TILLIE LEWIS DR
P_LOCATION
01
QC Status
Approved
Scanner
SJGOV\tsok
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
24
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
AdvancedGeo, Inc. <br />Coronavirus (Covid-19) Prevention and Control Plan <br />Page 3 of 6 <br />➢ Appropriate PPE, hygiene and cleaning supplies <br />Workplace Assessment per the Centers for Disease Control and Prevention (CDC) <br />RISK LEVEL TRAVEL-ASSOCIATED <br />EXPOSURES <br />EXPOSURES IDENTIFIED THROUGH CONTACT <br />INVESTIGATION <br />High N/A Living in the same household as, being an intimate <br />partner of, or providing care in a nonhealthcare setting <br />(such as a home) for a person with symptomatic <br />laboratory-confirmed COVID-19 infection without <br />using recommended precautions for home care and <br />home isolation <br />Medium (Assumes no <br />exposures in the high-risk <br />category) <br />Travel from a country <br />with widespread <br />sustained transmission <br />Travel from a country <br />with sustained <br />community transmission <br />Travel on a cruise ship <br />or river boat <br />Close contact with a person with symptomatic <br />laboratory-confirmed COVID-19 <br />On an aircraft, being seated within 6 feet (two meters) <br />of a traveler with symptomatic laboratory-confirmed <br />COVID-19 infection; this distance correlates <br />approximately with 2 seats in each direction <br />Living in the same household as, an intimate partner <br />of, or caring for a person in a nonhealthcare setting <br />(such as a home) to a person with symptomatic <br />laboratory-confirmed COVID-19 infection while <br />consistently using recommended precautions for <br />home care and home isolation <br />Low <br />(Assumes no exposures in <br />the high-risk category) <br />N/A Being in the same indoor environment (e.g., a <br />classroom, a hospital waiting room) as a person with <br />symptomatic laboratory-confirmed COVID-19 for a <br />prolonged period of time but not meeting the <br />definition of close contact <br />No identifiable risk N/A Interactions with a person with symptomatic <br />laboratory-confirmed COVID-19 infection that do not <br />meet any of the high-, medium- or low-risk conditions <br />above, such as walking by the person or being briefly <br />in the same room. <br /> <br />PERSONNEL IN CRITICAL INFRASTRUCTURE POSITIONS <br />Personnel who are permitted to work following an exposure should self-monitor under the <br />supervision of our occupational health program, including taking their temperature before each <br />work shift to ensure they remain afebrile. On days these individuals are scheduled to work, our <br />occupational health program could consider measuring temperature and assessing symptoms prior <br />to each employee starting work. <br />PROCEDURES FOR MANAGEMENT OF EXPOSED PERSONS BY RISK <br />LEVEL/PRESENCE OF SYMPTOMS <br />The public health actions recommended in the table below apply to people who have been <br />determined to have at least some risk for COVID-19. People who are being managed as <br />asymptomatic in a particular risk level, or who develop signs or symptoms compatible with <br />COVID-19, should be moved immediately into the symptomatic category in the same risk <br />level and be managed accordingly. The risk level does not change if symptoms develop. <br />
The URL can be used to link to this page
Your browser does not support the video tag.